pembrolizumab
merck
['kcsm,(-skcsm)', 'rcc,(-irccs),(-srcc),(-urcc)', 'pembro']
personally i'll probably continue using adjuvant pembro in resected rcc, especially for higher risk disease. curious what others think of the #esmo22 #kcsm periop io data 
Medical Oncologist @TexasOncology & @TheUSONetwork - focused on GU cancers and clinical trials - former fellow @MSKCancerCenter - tweets are my own